Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is a comparative drug trial involving patients with clinically definite Multiple
Sclerosis and documented neuropathic pain. Patients will be randomized to receive treatment
with either paroxetine or pregabalin. After dose titration, participants will complete
various pain scale assessments at several points during the study in order to determine the
effectiveness of their assigned pain medication.